What is a CDMO? CDMO stands for contract development and manufacturing organisations. They enable pharmaceutical companies to outsource drug manufacturing, allowing them to bring solutions to market faster whilst keeping expenses in check. Having aCDMO partnergives you instant access to expertise and equ...
Partner with a Qualified CDMO: UPM Pharmaceuticals Bringing a new drug to market is a lengthy, costly, and risky journey, compounded with the time pressure of being first in the marketplace. UPM is unlike other CDMOs because we are a large pharma supplier and an independent, family-owned CD...
A“Biopharma CDMO”? AMPACFine Chemicals, a Richmond, Virginia-based custom manufacturer of pharmaceutical fine chemicals, is singled out as one of Phlow’s strategic partners in all its initial plans. (In July of 2018, South Korea’s SK Holdings, and AMPAC announced SK's acquisition of 100...
The mRNA vaccines and therapeutics market is expected to exceedUSD 68 billionby 2030, with a CAGR of around 8.8% between 2023 and 2030. As leaders transform their mRNA development pipelines into market-ready therapeutics, the face of the market will shift massively. Evidence of that impending sh...
Business ModelOEM, ODM, Own Brand(sunbiolab), cdmoOEMOEMOEMOEM Average Lead TimeOff Season Lead Time: within 15 workdays Peak Season Lead Time: within 15 workdaysOff Season Lead Time: 1-3 months Peak Season Lead Time: 1-3 monthsOff Season Lead Time: 1-3 months ...
By partnering with a quality CDMO, pharmaceutical companies can get their small molecule drugs to market faster, helping to improve patient care and enhance health outcomes. In an upcoming blog post, we will explore large molecule drugs and their exponential rise in healthcare over the past few ...
A healthy planet is a priority for all of us. Catalent was the first CDMO to join the Pharmaceutical Supply Chain Initiative (PSCI), and we remain committed to it. Reducing carbon emissions while better managing waste and stewarding water resources will enable us to meet or excee...
Finally, CDMO executives will want to keep a close eye on their company’s spending, which can get out of hand when the business is growing rapidly. What if trade in pharmaceuticals becomes a victim of the trade war? The uncertainty surrounding international trade should be a matter of great...
The customer’s molecule is often ‘the life of their company’; so, they place a significant amount of trust when handing it off to a contract development and manufacturing organization (CDMO). They want more transparency in their molecule’s complex development and manufacturing process. A key...
a cross linking agent, or using a UV or radiation curing system, and thermal ovens can be used to accelerate the cross-linking process. With these, the adhesive will have a pot life once the reaction is started, so extra care and other techniques are utilized to ensure product c...